Moderna, Inc. (MRNA) on GreekSoup https://greeksoup.ai/stocks/us/mrna/ Every dated entry in the public record on Moderna, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 Moderna, Inc.: Hoge Stephen (President) sold 40,281 shares at $146.07 on 15 September 2026, $5.9 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-09-16:d982068bbeWed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Hoge Stephen (President) sold 40,294 shares at $144.13 on 14 September 2026, $5.8 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-09-16:f210acef9fWed, 16 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Hoge Stephen plans to sell 40,281 shares worth $5.9 million around 15 September 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-09-15:9eeaadecaeTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Hoge Stephen plans to sell 40,294 shares worth $5.8 million around 14 September 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-09-14:e4b05e8910Mon, 14 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Mock James M (Chief Financial Officer) sold 19,836 shares at $134.49 on 10 September 2026, $2.7 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-09-14:dcfdf19f74Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Mock James M (Chief Financial Officer) sold 15,000 shares at $134.49 on 10 September 2026, $2.0 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-09-14:b6ded30fe4Mon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Mock James M plans to sell 34,836 shares worth $4.7 million around 10 September 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-09-10:4e40e567c1Thu, 10 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Maria Elvira Salazar (FL27) disclosed a sale (partial), $1,001 - $15,000, traded 19 August 2026https://greeksoup.ai/stocks/us/mrna/congress/us:MRNA:congress:2026-09-09:f85dbd8198Wed, 09 Sep 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Maria Elvira Salazar (FL27) disclosed a purchase, $1,001 - $15,000, traded 19 August 2026https://greeksoup.ai/stocks/us/mrna/congress/us:MRNA:congress:2026-09-09:5d721db878Wed, 09 Sep 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Klinger Shannon Thyme (Chief Legal Officer) sold 3,471 shares at $139.95 on 1 September 2026, $485,766https://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-09-03:8e013646afThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc. filed 8-K: material agreement, new financial obligation, unregistered sale of equity, other eventshttps://greeksoup.ai/stocks/us/mrna/filings/us:MRNA:filing:2026-09-01:afb43277d7Tue, 01 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Klinger Shannon Thyme plans to sell 3,471 shares worth $485,766 around 1 September 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-09-01:8194f1a62bTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc.: short interest 39,151,532 shares at the 31 August 2026 settlement, 1.00 days to coverhttps://greeksoup.ai/stocks/us/mrna/short-interest/us:MRNA:short-interest:2026-08-31:276689399fMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Moderna, Inc.: short interest 52,809,184 shares at the 14 August 2026 settlement, 9.15 days to coverhttps://greeksoup.ai/stocks/us/mrna/short-interest/us:MRNA:short-interest:2026-08-14:d50e402f6eFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Schedule 13G filed by Capital World Investors, 5.6% of the classhttps://greeksoup.ai/stocks/us/mrna/holders/us:MRNA:schedule-13:2026-08-12:77cd4feaf1Wed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Bancel Stephane (Chief Executive Officer) sold 147,473 shares at $56.21 on 5 August 2026, $8.3 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-08-07:c958abf5fdFri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Bancel Stephane (Chief Executive Officer) sold 124,838 shares at $56.96 on 5 August 2026, $7.1 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-08-07:556c6dd27dFri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Bancel Stephane (Chief Executive Officer) sold 39,891 shares at $58.12 on 5 August 2026, $2.3 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-08-07:76d60f33c2Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Bancel Stephane (Chief Executive Officer) sold 187,044 shares at $58.79 on 5 August 2026, $11.0 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-08-07:c92961ca62Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Schedule 13G/A filed by FMR LLC, 13.1% of the classhttps://greeksoup.ai/stocks/us/mrna/holders/us:MRNA:schedule-13:2026-08-06:9a130ed759Thu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Bancel Stephane plans to sell 499,246 shares worth $29.0 million around 5 August 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-08-05:5d1d9bdee9Wed, 05 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc. Q2 FY2026 results: revenue $145 million, net income -$782 millionhttps://greeksoup.ai/stocks/us/mrna/results/fy2026-q2/us:MRNA:result:2026-07-31:dc56c4cea5Fri, 31 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Moderna, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/mrna/filings/us:MRNA:filing:2026-07-31:d2ab48ea2dFri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Moderna, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/mrna/filings/us:MRNA:filing:2026-07-31:5e4c3810d3Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Moderna, Inc.: short interest 49,768,882 shares at the 31 July 2026 settlement, 10.22 days to coverhttps://greeksoup.ai/stocks/us/mrna/short-interest/us:MRNA:short-interest:2026-07-31:143569e88eFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Schedule 13G/A filed by BAILLIE GIFFORD & CO, 4.6% of the classhttps://greeksoup.ai/stocks/us/mrna/holders/us:MRNA:schedule-13:2026-07-24:ff1ecf4ce2Fri, 24 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Hoge Stephen (President) sold 53,336 shares at $67.60 on 15 July 2026, $3.6 millionhttps://greeksoup.ai/stocks/us/mrna/insiders/us:MRNA:insider:2026-07-16:69e1159422Thu, 16 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Moderna, Inc.: Form 144, Hoge Stephen plans to sell 53,336 shares worth $3.6 million around 15 July 2026https://greeksoup.ai/stocks/us/mrna/planned-sales/us:MRNA:planned-sale:2026-07-15:4c5d7ea2c2Wed, 15 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Moderna, Inc.: short interest 52,401,842 shares at the 15 July 2026 settlement, 6.07 days to coverhttps://greeksoup.ai/stocks/us/mrna/short-interest/us:MRNA:short-interest:2026-07-15:48b7c8506dWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Moderna, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/mrna/filings/us:MRNA:filing:2026-07-08:2d679ed885Wed, 08 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Moderna, Inc.: short interest 53,185,640 shares at the 30 June 2026 settlement, 4.61 days to coverhttps://greeksoup.ai/stocks/us/mrna/short-interest/us:MRNA:short-interest:2026-06-30:8e9a056de5Tue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>